Discover 775 paid clinical trials in Washington, D.C.. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 775
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
for
Classic Follicular Lymphoma,
Location: Washington D.C. DC, Bethesda MD, Baltimore MD,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06337318
Phase 3, Recruiting
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Washington D.C. DC, Bethesda MD, Baltimore MD,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT04269902
Phase 3, Recruiting
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
for
Pancreatic Acinar Cell Carcinoma,
Location: Washington D.C. DC, Media PA, Paoli PA, Wynnewood PA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT04858334
Phase 2, Recruiting
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Location: Washington D.C. DC, Fairfax VA, Baltimore MD,
Sponsor: Janssen Research & Development, LLC
Sex: Male
Age: 18+
Code: NCT07164443
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
for
Carcinoma, Non-small-Cell Lung
Location: Washington D.C. DC, Fairfax VA, Baltimore MD,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT05498428
Phase 2, Recruiting
Cancer Experience Registry (CER) for Cancer Patients and Caregivers
for
Neoplasms, Cancer, Caregiver
Location: Washington D.C. DC
Sponsor: Cancer Support Community, Research and Training Institute, Philadelphia
A Study to Evaluate the Raindrop Near Vision Inlay Under Flap or Within Pocket
for
Presbyopia
Location: Washington DC
Sponsor: Whitten Laser Eye
Sex: All
Age: 40 - 70
Code: NCT03376412
Recruiting
A Prospective Study to Evaluate the Raindrop Near Vision Inlay in Presbyopic Patients With Treatments to Optimize the Ocular Surface Before Implantation
for
Presbyopia
Location: Washington, D.C. DC
Sponsor: Whitten Laser Eye
Sex: All
Age: 41 - 65
Code: NCT03126877
Recruiting
Safety and Efficacy Study of Intracystic TARA-002 for the Treatment of Lymphatic Malformations in Participants 6 Months to Less Than 18 Years of Age
for
Lymphatic Malformation
Location: Washington D.C. DC, Norfolk VA, New York NY,
Sponsor: Protara Therapeutics
Sex: All
Age: 0 - 18
Code: NCT05871970
Phase 2, Recruiting
Registry of Asthma Characterization and Recruitment 3 (RACR3)
for
Asthma
Location: Washington D.C. DC, New York NY, Cincinnati OH,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 0+
Code: NCT05272241
Recruiting
A Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature
for
Idiopathic Short Stature
Location: Washington D.C. DC, New York NY, The Bronx NY,
Sponsor: BioMarin Pharmaceutical
Sex: All
Age: 3 - 11
Code: NCT06382155
Phase 2, Recruiting
Hyperhydration in Children With Shiga Toxin-Producing E. Coli Infection
for
Shiga Toxin-Producing Escherichia Coli (E. Coli) Infection,
Location: Washington D.C. DC, Cleveland OH, Columbus OH, Hamilton,
Sponsor: University of Calgary
Sex: All
Age: 0 - 21
Code: NCT05219110
Recruiting
Technology-Enhanced Executive Functioning Intervention for ADHD
for
ADHD, Attention Deficit Hyperactivity Disorder,
Location: Washington DC
Sponsor: Children's National Research Institute
Sex: All
Age: 11 - 14
Code: NCT04729439
Phase 1, Recruiting
Systemic Biomarkers of Brain Injury From Hyperammonemia
for
Urea Cycle Disorder, Organic Acidemia,
Location: Washington DC
Sponsor: Children's National Research Institute
Sex: All
Age: 7 - 18
Code: NCT04602325
Recruiting
Protocol CAUSE-03 / CHEETAH
for
Asthma
Location: Washington D.C. DC, New York NY, Boston MA,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 6 - 17
Code: NCT06136091
Recruiting
New
A Clinical Study of Alimatravir (MK-8527) in Transgender (Trans) and Gender Diverse Individuals on Gender-affirming Hormone Therapy and at Low Likelihood of Human Immunodeficiency Virus (HIV)-1 Exposure (MK-8527-018)
for
HIV
Location: Washington D.C. DC, Philadelphia PA, Toronto, Boston MA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07850609
Phase 2, Recruiting
Questionnaire Study for Gynecological Cancer Survivors
for
Endometrial Neoplasms, Ovarian Neoplasms,
Location: Washington DC
Sponsor: U.S. Army Medical Research and Development Command
Sex: Female
Age: 20 - 70+
Code: NCT00391664
Recruiting
Comparison of the Tuberculin Skin Test (TST) and QuantiFERON ®-TB Gold Test (QFT-G) In Patients With Rheumatoid Arthritis Being Considered for Anti-TNF-Alpha Therapy